Cargando…

Chinese herbs in treatment of influenza: A randomized, double-blind, placebo-controlled trial

OBJECTIVE: To investigate the efficacy and safety of Antiwei, a traditional Chinese prescription, in the treatment of influenza. METHODS: In a multi-center, randomized, double-blind, placebo-controlled trial, we recruited 480 adults aged 18 to 65 years within 36 h of onset of influenza-like symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Zhang, Rui-Ming, Liu, Gui-Ying, Wei, Bao-Lin, Wang, Yang, Cai, Hong-Yan, Li, Feng-Sen, Xu, Yan-Ling, Zheng, Si-Ping, Wang, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127189/ https://www.ncbi.nlm.nih.gov/pubmed/20573492 http://dx.doi.org/10.1016/j.rmed.2010.05.015

Ejemplares similares

Chinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study
por: Chen, Chun-Chung, et al.
Publicado: (2012)

Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial
por: Hong, Minli, et al.
Publicado: (2018)

Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs
por: Zhang, Yufeng, et al.
Publicado: (2019)

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
por: Wang, Gang, et al.
Publicado: (2016)

Evaluation of a multi-herb supplement for erectile dysfunction: a randomized double-blind, placebo-controlled study
por: Shah, Gaurang R, et al.
Publicado: (2012)

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
por: Wang, Qin, et al.
Publicado: (2018)

A Randomized, Double-Blind, and Placebo-Controlled Trial of Chinese Herbal Medicine in the Treatment of Childhood Constipation
por: Qiao, Lei, et al.
Publicado: (2021)

Safety of red ginseng and herb extract complex (RHC) in menopausal women: A randomized, double-blind, placebo-controlled trial
por: Hyun, Sun Hee, et al.
Publicado: (2022)

Prediction Methods of Herbal Compounds in Chinese Medicinal Herbs
por: Han, Ke, et al.
Publicado: (2018)

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
por: Xu, Rui-Hua, et al.
Publicado: (2017)

Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial
por: Liu, Jun, et al.
Publicado: (2014)

A double‐blind, placebo‐controlled trial on the antihypertensive treatment effect of a quadruple single‐pill combination
por: Hu, Lei‐Xiao, et al.
Publicado: (2021)

Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study
por: Martinez-Horta, Saul, et al.
Publicado: (2021)

Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial
por: Hu, Xiao-Yang, et al.
Publicado: (2022)

Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study
por: Zhang, Hui, et al.
Publicado: (2020)

Efficacy and safety of aildenafil citrate in Chinese men with erectile dysfunction: a multicenter, randomized, double-blind, placebo-controlled crossover trial
por: Cui, Wan-Shou, et al.
Publicado: (2021)

Review on “Long-Dan”, one of the traditional Chinese medicinal herbs recorded in Chinese pharmacopoeia
por: Wang, Yan-Ming, et al.
Publicado: (2012)

RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial
por: Yang, Shuo, et al.
Publicado: (2023)

Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
por: Zhang, Zhenxin, et al.
Publicado: (2018)

Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
por: Chai, Meng, et al.
Publicado: (2023)

A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder
por: Zhang, Ling, et al.
Publicado: (2022)

Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Qin, et al.
Publicado: (2020)

Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
por: Li, Yan, et al.
Publicado: (2021)

Chinese Medicinal Formula (MHGWT) for Relieving Diabetic Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Tsai, Chia-I, et al.
Publicado: (2013)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Liu, Ningning, et al.
Publicado: (2020)

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
por: Qi, Litong, et al.
Publicado: (2023)

The complete chloroplast genome of Isodon rubescens, a traditional Chinese herb
por: Yue, Zhiyong, et al.
Publicado: (2021)

Research Advances in Multi-Omics on the Traditional Chinese Herb Dendrobium officinale
por: Wang, Yue, et al.
Publicado: (2022)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
por: Li, Li, et al.
Publicado: (2022)

The pharmacology of Chinese herbs /
por: Huang, K. C. (Kee Chang), 1917-
Publicado: (1999)

Polysaccharides from Chinese herbs as natural weapons against colorectal cancer
por: Zhou, Mingyue, et al.
Publicado: (2023)

Systems Biology of Meridians, Acupoints, and Chinese Herbs in Disease
por: Lin, Li-Ling, et al.
Publicado: (2012)

Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Yan, Lijing, et al.
Publicado: (2019)

Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial
por: Chang, Jing, et al.
Publicado: (2012)

Detection of Herb-Symptom Associations from Traditional Chinese Medicine Clinical Data
por: Li, Yu-Bing, et al.
Publicado: (2015)

Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study
por: Yan, Chong, et al.
Publicado: (2022)

Structural Elucidation, Modification, and Structure-Activity Relationship of Polysaccharides in Chinese Herbs: A Review
por: Wang, Bei, et al.
Publicado: (2022)

JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial
por: Wang, Hui, et al.
Publicado: (2017)

Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double‐blind, controlled phase I clinical trial
por: Li, Yan‐Ping, et al.
Publicado: (2012)

CARDIAC DISORDER IN HEMODIALYSIS: BENEFITS OF CHINESE HERBS
por: Lü, ZhongQing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_apugld6j3sn5l1k98r8torf3lh